WANG, LONGGUI,LIU, XIAO MEI,MO, LIAN,MENCHER, SIMON K.,MCCARRON, JAMES P., JR.
申请号：
CA2547963
公开号：
CA2547963C
申请日:
2005.01.06
申请国别(地区):
CA
年份:
2015
代理人:
摘要：
The invention relates to pharmaceutical compositions and methods of treatinginflammatory-related diseases associated with pro-inflammatory cytokineexpression and/or reduced expression of anti-inflammatory cytokines. Themethod typically comprises administration of one or more compounds selectedfrom isoindigo, indigo, indirubin, or derivatives thereof, such as,Meisoindigo and NATURA. Preferably the pharmaceutical composition comprisesone or more compounds selected from isoindigo, indigo, indirubin, orderivatives thereof, an anti-inflammatory agent, and a pharmaceuticallyacceptable carrier.
